Related Experiment Video
Updated: Jul 17, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia
Ameek S Bhogal1, Maria L Lorite, Michael J Tisdale
1Biomedical Science, School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, UK.
Background:
To investigate factors responsible for muscle loss in cachexia changes in nucleic acid and protein levels have been determined and compared with those induced by a tumour-produced cachectic factor, proteolysis-inducing factor (PIF).
Materials And Methods:
Mice were transplanted with the MAC16 tumour, while non-tumour bearing mice received PIF (1.5 mg/kg; i.v.) over a 24 h period.
Results:
There was an exponential decrease in RNA and protein in gastrocnemius muscle with weight loss without an effect on the DNA content. Levels of myosin followed the decrease in total protein, while actin levels remained constant. There was also a significant loss of protein from soleus muscle and spleen, but not from heart, liver and kidney. PIF also produced a significant loss of RNA and protein in spleen and reduced the protein content of soleus muscle.
Conclusion:
This suggests that PIF may be responsible for changes in protein and RNA content of tissues with the development of cachexia.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Cross-bridge Cycle
The Nucleolus
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cellular Adaptation I: Introduction and Atrophy
